cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation Instruct...

FDA Device Recall #Z-1830-2016 — Class II — March 15, 2016

Recall Summary

Recall Number Z-1830-2016
Classification Class II — Moderate risk
Date Initiated March 15, 2016
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Roche Molecular Systems, Inc.
Location Branchburg, NJ
Product Type Devices
Quantity 8 kits

Product Description

cobas¿ EGFR Mutation Test, v2 and cobas¿ cfDNA Sample Preparation Hungarian Translation Instructions for Use

Reason for Recall

An error was found within the Hungarian translations of the cobas¿ EGFR Mutation Test v2 Instructions for Use (M/N 07340761001-01HU, Doc Rev. 1.0, Dated 08/2015) and the cobas¿ cfDNA Sample Preparation Kit Instructions for Use (M/N 07573758001-01HU, Doc. Rev. 1.0, Dated 05/2015).

Distribution Pattern

Hungary

Lot / Code Information

EGFR v2: 07248563190 cfDNA: 07247737190

Other Recalls from Roche Molecular Systems, Inc.

Recall # Classification Product Date
Z-1104-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative as... Dec 21, 2022
Z-1106-2023 Class II cobas Influenza A/B & RSV UC (Utility Channel) ... Dec 21, 2022
Z-1105-2023 Class II cobas SARS-CoV-2 & Influenza A/B Qualitative nu... Dec 21, 2022
Z-0097-2023 Class II cobas 5800 instrument, Material No. 08707464001... Sep 8, 2022
Z-0828-2022 Class II cobas LiatSystem, respiratory virus panel nucle... Nov 16, 2021

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.